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Brain hyperexcitability in sleep apnea is believed to be provoked by hypoxemia, but sleep fragmentation can also play a significant 
role. Sleep fragmentation can trigger inflammatory mechanisms. The aim of this research was to investigate the effects of chronic 
sleep fragmentation on seizure susceptibility and brain cytokine profile. Chronic sleep fragmentation in male rats with implanted EEG 
electrodes was achieved by the treadmill method. Rats were randomized to: treadmill control (TC); activity control (AC) and sleep 
fragmentation (SF) group. Convulsive behavior was assessed 14  days later by seizure incidence, latency time and seizure severity 
during 30 min following lindane administration. The number and duration of EEG ictal periods were determined. Levels of IL‑1β and 
IL‑6 were measured in the animals’ serum and brain structures (hippocampus, thalamus and cerebral cortex), in separate rat cohort 
that underwent the same fragmentation protocol except lindane administration. Incidence and severity of seizures were significantly 
increased, while latency was significantly decreased in SF+L compared with TC+L group. Seizure latency was also significantly decreased 
in SF+L compared to AC+L group. The number and duration of ictal periods were increased in the SF+L compared to the AC+L group. 
IL‑1β was significantly increased in the thalamus, cortex and hippocampus in the SF compared to the AC and TC groups. IL‑6 was 
statistically higher only in the cortex of SF animals, while in the thalamic or hippocampal tissue, no difference was observed between 
the groups. It could be concluded that fourteen‑day sleep fragmentation increases seizure susceptibility in rats and modulates brain 
production of IL‑1β and IL‑6. 
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INTRODUCTION
Sleep fragmentation is defined as a series of brief 
arousals repeated consecutively throughout the night 
(Bonnet and Arand, 2003). This type of fractured sleep 
causes excessive daytime sleepiness, impaired cogni‑
tion and numerous neurobehavioral deficits (Bonnet 
and Arand, 2003; Vijayan, 2012). Clinical and transla‑
tional studies suggested certain lifestyle factors may 
be important modulators of epilepsy, elucidating those 
related to sleep as particularly important. Shift work 
and social jetlag caused by modern lifestyles are ac‑
companied by quantitative and qualitative sleep alter‑
ations. An altered sleep pattern has been already rec‑
ognized as a cause of behavioral changes, but recent 
evidences suggest a bidirectional relationship between 
the psychiatric illnesses, disrupted circadian rhythm 
and disrupted sleep (Wulff et al., 2010). Since total 
sleeping time in fragmented sleep is insignificantly 
changed, most scientists tend to attribute these conse‑
quences to periodic interruptions and stress (Devinsky 
et al., 1994). 
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Patients with wide variety of diseases, particular‑
ly those with obstructive sleep apnea (OSA) often suf‑
fer from fragmented sleep (Day et al., 1999). Treating 
sleep apnea can be crucial to epilepsy prevention and 
treatment (Malow et al., 2000; Chihorek et al., 2007). 
It is believed that the main cause of hyperexcitability 
in patients with OSA is hypoxemia (Manni and Tartara, 
2000; Seyal et al., 2010), but many researchers in the 
field are of the opinion that sleep fragmentation, as an 
accompanying phenomenon, should also be considered 
as a powerful contributing factor (Ferrillo et al., 2000; 
Parrino et al., 2000; Manni et al., 2005; Seyal et al., 2010; 
Foldvary‑Schaefer et al., 2012). 
Numerous uncertainties exist on mechanisms of in‑
creased neuronal excitability upon sleep alterations. 
It is known that sleep fragmentation can trigger 
low‑grade chronic inflammatory mechanisms (Mulling‑
ton et al., 2009; Tang et al., 2009). Moreover, systemic or 
central nervous system inflammation exerts the mod‑
ulation of synaptic plasticity via neuroinflammatory 
mediators, thus influencing brain neuronal networks 
functioning (Di Filippo et al., 2013; Hrncic et al., 2018; 
Šutulović et al., 2019). An increased production of dif‑
ferent cytokines, especially IL‑1β, TNF‑α and IL‑6 in ac‑
tivated astrocytes and microglia during epileptogene‑
sis, has been already proven in several studies (Ravizza 
et al., 2008; Vezzani and Friedman, 2011). Indeed, these 
cytokines play various roles through multiple path‑
ways and mediate complex connections between the 
immune system and epilepsy (Li et al., 2011). 
Since epilepsy nowadays presents a major society 
burden, with the prevalence of 0.5–1.0% (Hauser et al., 
1991) and 30% of affected individuals having continu‑
ous seizures despite antiepileptic drugs (AEDs) (Sand‑
er, 1993). The reduction of factors which may promote 
seizures, such as sleep fragmentation (Rajna and Veres, 
1993; Frucht et al., 2000), could lead to new and more 
effective treatment strategies. In this study we used 
the lindane model of experimentally induced general‑
ized seizures, as described earlier (Vučević et al., 2008; 
Hrnčić et al., 2016), because lindane induced seizures 
are refractory to numerous classical antiepileptic drugs 
and therefore believed to be suitable for exploration of 
refractory epilepsy (Vučević et al., 2008).
The objective of this study was to investigate the 
effects of chronic sleep fragmentation on seizure sus‑
ceptibility using an experimental model of lindane‑in‑
duced seizures and a high frequency sleep disruption 
model of sleep fragmentation characteristic for ob‑
structive sleep apnea. We also wanted to examine the 
effect of sleep fragmentation on the IL‑1beta and IL‑6 
levels in the hippocampus, thalamus and cortex of rat’s 
brain tissue, and see if they could bridge the missing 
link between these disorders.
METHODS
Animals and housing
Two months old male Wistar albino rats were used. 
The animals were obtained from the Military Medical 
Academy breeding laboratory (Belgrade, Serbia). Rats 
were housed in separate transparent plastic cages 
(55 cm × 35 cm × 15 cm), they were given 25‑30 g of 
food (Purina rat chow) per day and had free access to 
water (ad libitum access) continuously. Ambient condi‑
tions were set up to an optimal breeding conditions, 
i.e., 22‑24°C, 50±5% relative humidity, 12:12 h light/
dark cycle with light switched on from 8:00 h to 20:00 h. 
One week was the period of adaptation to these envi‑
ronmental conditions upon rat arrival in the laborato‑
ry. All animals were not used more than once in the 
experimental procedures. 
All experimental procedures were approved by the 
Ethical Committee of the Faculty of Medicine, Univer‑
sity of Belgrade and were in full compliance with the 
European Council Directive (2010/63/EU). 
Implantation of intracranial electrodes  
for electroencephalographic (EEG) recordings: 
EEG registration and analysis
Three gold‑plated screws were implanted into the 
skull of the animals for EEG recordings. Prior to the 
procedure rats were anaesthetized with intraperitone‑
al injection (i.p.) of sodium pentobarbital (50 mg/kg), 
and positioned in a stereotaxic apparatus afterwards. 
Recording electrodes were implanted over frontal 
(2 mm rostrally to bregma and 2 mm from the median 
line), parietal (2 mm rostrally to lambda and 2 mm lat‑
erally to median line) and occipital (2 mm caudally to 
lambda) cortices. 
Upon 7‑day recovery period, rats had 24 h habitua‑
tion to the EEG recording settings with a full cable set‑
up attached.
A classical 8‑channel EEG apparatus (RIZ, Zagreb, 
Croatia), with a modified output degree enabling the 
transfer of output signals to the input circuit of 12‑byte 
AD card PCL‑711B (Advantech Co. Ltd.) and sampling 
frequency of 512 Hz/channel installed into a comput‑
er, was used. The signals were digitized using a SCB‑68 
data acquisition card (National Instruments Co, Austin, 
Texas, USA). Data acquisition and signal processing 
were performed with the Lab VIEW platform software 
developed in the NeuroSciLaBG Laboratory (Stanojlović 
et al., 2009; Hrnčić et al., 2011). Following parameters 
of signal processing were applied: 50 Hz notch filter for 
ambient noise removal, and 0.3 Hz and 100 Hz the cut‑
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off frequencies for the high‑pass and low‑pass filters, 
respectively. All EEG recordings sessions lasted 30 min 
and were visually monitored. Criteria for EEG ictal pe‑
riod identification were: spontaneous and generalized 
spiking activity; lasting more than 1s., and amplitude 
of at least twice the background EEG activity.
We analyzed the number and duration of ictal peri‑
ods using left frontal‑right parietal cortex lead, since 
recorded electrographic seizures were generalized 
with simultaneous and comparable ictal activity in all 
leads. All ictal periods were detected visually.
Chronic sleep fragmentation
A forced awakening‑protocol was used in order to ex‑
perimentally fragment sleep over the period of 14 con‑
secutive days. Sleep fragmentation was achieved by an 
established methodology as previously described (McK‑
enna et al., 2007; Hrnčić et al., 2016; Grubac et al., 2019) 
in details using the first 6 h of light phase of the light/
dark cycle as a fragmentation period. This method uti‑
lizes the protocol based on treadmill apparatus for small 
animals, which was applied to the control group, addi‑
tional control locomotor activity group and the study 
group subjected to sleep fragmentation. Briefly, tread‑
mill activity was defined by ON mode (working mode, 
belt moving) at the speed of 0.02 m/s and OFF mode 
(stop mode) at the speed of 0.00 m/s. The treadmill was 
programmed to work alternately for 30 s ON and 90 s 
OFF every 2 min during the entire period of 6 h in or‑
der to achieve sleep fragmentation (sleep fragmentation 
protocol SF, 180 consecutive cycles in total; n=18) similar 
to one in patients with OSA. The corresponding activity 
control protocol was also included in the study to avoid 
any confounding effects of the movement itself, i.e., the 
total movement of the rats was equal to the SF group, 
but without interruption of their sleep during longer 
periods of time (10 min ON and 30 min OFF, activity con‑
trol protocol, AC; n=18). The treadmill control consist‑
ed of rats staying in the treadmill apparatus at moving 
speed of 0 m/s and conditions equivalent to those in the 
cages (treadmill control protocol: TC, consecutive cycles 
in total over 6 h, n=18). After each treadmill session, the 
rats from the SF, AC and TC protocols were transferred to 
home cages and the procedure was repeated in the same 
manner the next day for fourteen consecutive days.
On the 15th day, one third of the animals from each 
protocol received intraperitoneal injection of subcon‑
vulsive dose of lindane (L, 4 mg/kg) according to our 
previous study (Hrnčić et al., 2016), comprising the 
SF+L, AC+L and TC+L group (n=6 per group). Lindane 
was dissolved in dimethylsulfoxide (DMSO) immedi‑
ately prior to use. The other third of the animals from 
each protocol received only DMSO, comprising the SFc, 
ACc and TCc groups (n=6 per group), which served as 
control groups to chemoconvulsant.
The remaining third of the animals from the SF, AC 
and TC protocol (SF, AC, TC, n=6 per group) were imme‑
diately sacrificed to obtain serum and brain structure 
isolation for determination of cytokines.
The study design time‑flow chart is presented in 
Fig. 1.
Convulsive behavior
Convulsive behavior parameters were observed 
30 min upon lindane injection and were defined as fol‑
low: incidence – number of convulsing rats in group, 
expressed as percentage; latency period – time between 
lindane administration and first convulsion and seizure 
severity – modified descriptive scale with grades from 
0 to 4. The grades were defined as in our previous stud‑
ies (Stanojlović et al., 2009): 0 – no convulsive behav‑
ior; grade 1 – head nodding, lower jaw twitching; grade 
2 – myoclonic body jerks (hot plate reaction), bilateral 
forelimb clonus with full rearing (Kangaroo position); 
3 – progression to generalized clonic convulsions fol‑
lowed by tonic extension of fore and hind limbs and tail 
and grade 4 prolonged severe tonic‑clonic convulsions 
lasting over 5 min (status epilepticus).
Determination of interleukin levels
Blood samples were collected from the tail vein, and 
centrifuged at 1575 g for 10 min and frozen at ‑20°C 
until assayed for cytokine levels. Duplicate serum al‑
iquots for all analyses were used. Brain levels of IL‑1 
beta and IL‑6 were determined in rats from the SF, AC 
and TC groups (n=6). These groups have undergone the 
same protocol of sleep fragmentation like SF+L, AC+L 
and TC+L and SFc, ACc and TCc, but were sacrified on 
day 15th, at 8th a.m. by decapitation (so it wouldn’t in‑
terfere with the IL levels), instead of being treated with 
lindane or DMSO, respectively. The isolation of brain 
and dissection of the hippocampus, thalamus and fron‑
to‑parietal cerebral cortex was performed in the pre‑
viously described method (Paxinos and Watson, 2007). 
All tissue samples were homogenized on ice in the com‑
mercial RIPA buffer (Sigma‑Aldrich, USA) supplement‑
ed with protease inhibitory cocktail (#P8340, Sigma‑Al‑
drich, USA) and stored at ‑80°C until further usage. 
The IL‑1β and IL‑6 concentrations were assayed in the 
above‑mentioned brain structures using the commer‑
cial ELISA kit (Rat IL‑1β ELISA Kit, Sigma‑Aldrich, USA 
and Rat IL‑6 ELISA Kit, Sigma‑Aldrich, USA) according 
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to manufacturer’s instructions which did not require 
any specific protein isolation procedure apart from the 
aforementioned homogenization. Briefly, sandwich as‑
say procedure included addition of samples/standards 
into antibody pre‑coated wells with an overnight at 4°C 
incubation after which biotin‑labelled detection anti‑
body was added. Concentrations of IL‑1β and IL‑6 were 
calculated based on standard curve plot. 
Data analysis
The statistically significant difference in the inci‑
dence was determined by using Fisher’s exact proba‑
bility test. The non‑parametric Kruskal‑Wallis ANOVA 
and Mann‑Whitney U tests were applied in further 
data analyses for the assessment of statistically sig‑
nificant difference between group since the normal 
data distribution of the data regarding latency period, 
convulsive episodes’ severity, as well as number and 
duration of ictal periods in EEG, has not been deter‑
mined by the Kolmogorov‑Smirnov test (*p<0.05 and 
**p<0.01). On the other hand, the normal distribution 
of the data on interleukin levels has been proven by 
the Kolmogorov‑Smirnov test and one‑way ANOVA, 
with LSD post hoc testing used to evaluate differences 
in interleukin levels between groups. For parametric 
variables, data were presented with means ± standard 
error, while non‑parametric variables were presented 
as medians with 25th and 75th percentiles. Significance 
was set as p<0.05. 
RESULTS
Convulsions analysis
There were no seizures in the SFc, ACc and TCc 
groups, while seizures have been noted in every lin‑
dane‑treated group. The incidence of seizures was 
highest in the SF+L group, where they were uniformly 
present (incidence=100%). The incidence in the SF+L 
group was significantly higher compared to the AC+L 
group, with the incidence of 33.33% (Fisher’s exact 
P=0.0303, Fig. 2), and also compared to the TC+L group, 
which demonstrated the incidence of 16.67% (Fisher’s 
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Fig. 1. Schematic illustration of experimental design time flow. Upon animal arrival, acclimatization to laboratory conditions was allowed for 7 days. 
Sleep fragmentation was achieved by procedure using treadmill for small laboratory animals. Prior to fragmentation all animals were adapted to the 
moving of the treadmill track for 2 days in sessions of 1 h (5 min ON and 5 min OFF working regime, treadmill belt speed ON=0.02 m/s, OFF=0 m/s). 
For the sleep fragmentation procedure (its beginning is denoted as day 1 at time line), animals (n=54) were subjected to one of the three protocols 
(n=18 in each) in the treadmill during 6 h of the light period (between 8 a.m. – 2 p.m.) for 14 consecutive days: sleep fragmentation protocol (SF: 
30 s OFF: 90 s ON regime, 30 sleep interruptions per h), activity control protocol (AC: 10 min ON: 30 min OFF regime, 1.5 sleep interruptions per 
h), treadmill control protocol (TC: constantly OFF regime, 0 sleep interruptions per h). On the 15th day, one third of the animals from each protocol 
received lindane (L) comprising the SF+L, AC+L and TC+L groups (n=6 per group). The other third of the animals from each protocol received only 
vehicle, comprising the SFc, ACc and TCc groups (n=6 per group), which served as control groups to chemoconvulsant. The remaining third of the 
animals (n=6 per group) form each protocol (SF, AC and TC group) were immediately sacrificed to obtain serum and brain structure isolation for 
determination of cytokines.
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exact P=0.0076, Fig. 2). There was no significant differ‑
ence in incidence between the TC+L and AC+L group 
(33.33% vs. 16.67%, Fisher’s exact P=0.5000, Fig. 2).
The next parameter of convulsive behavior re‑
sponse that we analyzed was latency time to first sei‑
zure sign upon lindane administration. Kruskal‑Wal‑
lis ANOVA showed significant (H2=12.15, P<0.05) dif‑
ference in latency time among TC+L, AC+L and SF+L 
group. Latency time was significantly shorter in the 
SF+L group than in the TC+L (U=0.50, z=2.85, P<0.01) 
and AC+L groups (U=13.00, z=2.75, P<0.01, Fig. 3A). Al‑
though the median latency to seizure was somewhat 
shorter in the AC+L group compared to the TC+L, the 
difference was not statistically significant (U=13.00, 
z=0.85, P>0.05, Fig. 3A). 
Grading the severity of seizures using the behav‑
ioral scale previously described, median value in SF+L 
group was 2, with some animals reaching even grade 
4 (Fig. 3B). Severity in other groups were similar, with 
both the AC+L and TC+L groups having the median 
grade 0, albeit somewhat higher range was observed 
in the AC+L group (Fig. 3B). Kruskal‑Wallis ANOVA 
showed significant (H2=9.13, P<0.05) difference in se‑
verity of seizures among TC+L, AC+L and SF+L group. 
Statistically, the severity in the SF+L group was statis‑
tically higher compared to the TC+L group (U=13.00, 
z=‑2.77, P<0.01). There were no statistically significant 
differences AC+L vs. SF+L (U=6.00, z=‑1.91, P>0.05) and 
TC+L vs. AC+L (U=14.00, z=‑0.74, P>0.05). 
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Fig.  2. Incidence of seizures in sleep‑fragmented lindane‑treated ani‑
mals. After being adapted to the environment and on the 14th day upon 
completion of sleep fragmentation protocol, Lindane (L), was admin‑
istered. Rats were distributed into following groups: treadmill control 
(TC+L, treadmill protocol OFF only), activity control (AC+L, alternating 
treatmill protocol 10  min ON and 30  min OFF), sleep fragmentation 
(SF+L, treadmill protocol 30 s ON and 90 s OFF). Seizure incidence was 
expressed as convulsive rats percentage (%) of total. Fisher’s exact 
probability test was performed for statistical assessment (**p<0.01).
Fig. 3. Latency to convulsions and intensity of seizures (seizure grade). Latency to seizure is expressed as minutes elapsed following lindane admin‑
istration to the occurrence of first convulsive signs. Statistical significance was examined using the Kruskal‑Wallis ANOVA followed by Mann‑Whitney 
U‑test. (**p<0.01 vs. TC+L, ##p<0.01 vs. AC+L). (B) Lindane‑provoked seizure intensity grade. Seizures were graded based on behavioral observations 
in convulsive rats based on a descriptive scale: 0: no seizure; 1: head nodding, lower jaw twitching; 2: “hot plate reaction” (myoclonic body jerks), 
‘’Kangaroo position’’ (bilateral forelimb clonus with full rearing); 3: generalised tonic‑clonic seizures with extension of fore and hind limbs and tail; 
4: status epilepticus (tonic‑clonic seizures lasting over 20 s) or frequently repeated episodes of clonic convulsions for an extended period of time 
(over 5 min). Statistical significance was examined using the Kruskal‑Wallis ANOVA followed by Mann‑Whitney U‑test. (**p<0.01 vs. TC+L as well as 
vs. AC+L).
Sleep fragmentation related seizures and neuroinflammation Acta Neurobiol Exp 2021, 81
EEG analysis 
The EEG activity in rats from the control SFc, ACc and 
TCc groups showed no signs of ictal activity (Fig. 4A, C, E). 
Rats from groups receiving lindane developed ictal activi‑
ty in EEG consisting of sporadic, smaller groups or series of 
high‑amplitude spikes (EEG ictal periods, Fig. 4B, D, F). We 
analyzed the number and duration of these ictal periods. 
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Fig. 4. Representative EEG tracings recorded in TCc, ACc and SFc groups (A, C, E) and TC+L, AC+L and SF+L groups (B, D, F). The number (G) 
and duration (H) of EEG ictal periods upon lindane administration. Representative EEG tracings recorded in control groups (TCc, ACc and 
SFc, A, C, E) showing baseline activity without signs of epileptiform discharges. Ictal activity has been recorded upon lindane administration 
in TC+L, AC+L and SF+L group (B, D, F) in form of spike bursts of different duration and number. Lead: left frontal–right parietal cortex. The 
number (G) and duration (H) of ictal periods was measured during 30 min EEG recordings upon lindane administration. The significance 
of the differences between the groups was estimated by Kruskal‑Wallis ANOVA and Mann‑Whitney U test (**p<0.01 vs. TC+L, ##p< 0.01 vs. 
AC+L).
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According to Kruskal‑Wallis ANOVA, number of ic‑
tal periods was significantly different (H2=13.28, P<0.05) 
among the groups receiving lindane (TC+L, AC+L and 
SF+L). The SF+L group exhibited significantly higher 
number of ictal periods per rat in comparison to the 
TC+L (U=0.00, z=‑2.81, P<0.01), as well as in comparison 
to the AC+L group (U=0.00, z=‑2.80, P<0.01, Fig. 4G). At 
the same time, there were no statistically significant 
differences between the AC+L and TC+L groups regard‑
ing the number of ictal periods per rat (U=5.50, z=‑1.94, 
P>0.05), Fig. 4G), On the other hand, the same holds true 
for duration of ictal period among the groups receiving 
lindane (TC+L, AC+L and SF+L, H2=15.67, P<0.01, Fig. 4H).
Interleukin analysis
According to one‑way ANOVA analysis, there were 
significant differences (F2,15=7.22, P<0.01) among TC, AC 
and SF group in IL‑1β hippocampal levels. Post hoc anal‑
ysis showed that hippocampal levels of IL‑1β showed 
significant increase in the SF group contrasted with 
both the TC (P<0.01) and AC groups (P<0.05, Fig. 5C). 
IL‑1β levels were noted to be higher in the AC group 
compared to TC, but the difference was not statistical‑
ly significant (P>0.05, Fig. 5C). Similar distribution has 
been observed in the thalamus (F2,15=63.28, P<0.01), with 
the SF group having the highest IL‑1β level among the 
three groups (P<0.01 vs. both AC and TC, Fig. 5E). Again, 
AC group levels were higher than in the TC group, but 
not statistically significant (P>0.05, Fig. 5E). The same 
holds true for IL‑1β in the cortex (F2,15=5.31, P<0.05): 
the SF group expressed significantly higher level of 
IL‑1β compared to both the TC (P<0.05) and AC groups 
(P<0.05, Fig. 5A), while no significant differences be‑
tween TC and AC group were observed (P>0.05, Fig. 5A).
In contrast to hippocampal IL‑1β, the hippocampal 
levels of IL‑6 post‑hoc analysis revealed that the SF 
group had the lowest values among the three groups, 
the TC group levels were somewhat higher, and the AC 
group had the highest IL‑6 level values; however, no 
statistical significance was noted in the observation 
(F2,15=0.88, P>0.05, Fig. 5D). Thalamic IL‑6 levels were 
distributed in the following manner: SF<TC<AC, but no 
statistical significance was obtained (F2,15=0.08, P>0.05, 
Fig. 5F). On the other hand, according to one‑way 
ANOVA analysis, there were significant differences 
(F2,15=4.67, P<0.05) among TC, AC and SF group in IL‑6 
levels in the cortex, IL‑6 was higher in the cortex of 
animals from the SF group vs. the animals from the TC 
and AC group (P <0.05, Fig. 5B). 
Serum levels of IL‑1β and IL‑6 showed no statisti‑
cal difference between groups (F2,15=0.71, P>0.05; Fig. 6A 
and F2,15=0.88, P>0.05, Fig. 6B, respectively).
DISCUSSION
The effects of altered sleep pattern are known to 
have profound effects on seizure susceptibility, and 
the role of total or partial sleep deprivation in patients 
with epilepsy has been already explained (Scalise et al., 
2006; Lucey et al., 2015). However, the relationship be‑
tween sleep fragmentation and epilepsy has not been 
studied extensively. Sleep fragmentation is common 
in patients with sleep apnea (Day et al., 1999), which 
consists of abnormal breathing as a main symptom and 
cyclic appearance of sleep interruptions with frequen‑
cy of 30 or more times per h in severe forms (Devin‑
sky et al., 1994). In our previous study, we have prov‑
en that acute sleep fragmentation of 6 h in the light 
phase of the light/dark cycle potentiated epileptic ac‑
tivity in rats by increasing the number of seizures and 
their severity, while shortening the seizure latency at 
the same time (Hrnčić et al., 2016). However, one of the 
major limitations of that study was the length of the 
induced fragmentation, i.e., chronic effects have not 
been evaluated in that study. It should be emphasized 
that the effects of acute and chronic sleep interruption 
are quite different in terms of stress response, somatic 
pain, reduced quality of life, emotional distress, mood 
disorders, and cognitive, memory, and performance 
deficits (Medic et al., 2017). In both, our previous and 
this research we used the model of sleep fragmentation 
which mimic the sleep disturbance in patients with 
proven OSA (Grubac et al., 2019). We should emphasize 
that, using this specific pattern of fragmentation, shift 
in the circadian rhythm or REM rebound effect is pos‑
sible or even likely to happen, however that matter is 
irrelevant in our case since it also occurs in everyday 
situations with OSA.
There are several assumptions regarding the under‑
lying cause of the difference between acute and chron‑
ic effects, ranging from alternations in HPA axis (hypo‑
thalamic‑pituitary‑adrenal) (Bonnet and Arand, 2003) 
to REM rebound effect in chronic sleep loss (Shrivas‑
tava et al., 2014) and modified sleep architecture (Bon‑
net and Arand, 2003). However, a definite answer to this 
question has not been given yet. In the present study we 
have decided to evaluate the effects of long‑term sleep 
fragmentation which lasted for 14 consecutive days in 
accordance with Baud et al. (2015), with the difference 
in duration of the fragmented period since Baud et al. 
used 24 h fragmentation, and on the other hand we 
used only 6 h/24 h sleep fragmentation which is, in our 
opinion, better for understanding its effects due to the 
fact that the period of 6 h is average sleeping time. The 
effects of long‑term sleep fragmentation were more 
severe than the effects of the short‑term in our previ‑
ous research, increasing not only seizure susceptibility 
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Fig. 5. Interleukin levels in rat brain structures – cortex, thalamus and hippocampus. (C) demonstrated significantly higher values in SF group compared 
to others (**p<0.01 vs. TC, #p<0.05 vs. AC). The results were similar in both: thalamic IL‑1β levels (E), with SF group having the highest value (***p=0.001 
vs. TC, ###p=0.001 vs. AC) and cortex IL‑ β levels (A) (SF vs. TC, *p<0.05; SF vs. AC, #p<0.05; AC vs. TC p>0.05). IL‑6 levels were also analyzed in rat hippo‑
campi (D), thalami (F) and cortex (B). Difference in IL‑6 levels among the three groups was not statistically significant in the hippocampus and thalamus 
(p>0.05 vs. both TC and AC) while significant difference was observed in cortex (*#p<0.05 vs. both TC and AC). Statistical significance was tested using 
Student’s T‑test.
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but inducing both behavioral and EEG epileptic activity 
after administration of lindane in subconvulsive dose. 
Our present data also showed significant increase of 
IL‑1β levels in the thalamus, cerebral cortex and hip‑
pocampal tissue in rats undergoing protocol of chronic 
sleep fragmentation compared to the corresponding 
controls. In addition, the levels of IL‑6 were significant‑
ly increased in the cortex of sleep fragmented animals, 
but no statistical difference was found in the thalamus 
or hippocampus. 
Sleep fragmentation and intermittent hypoxia are 
hallmarks of OSA in which reduction in seizure thresh‑
old has been reported (Malow et al., 2003). Unanswered 
question in the contemporary literature is to which 
extent sleep fragmentation contribute to this seizure 
threshold reduction in apneic patient. Our study as‑
sessed this question from the viewpoint of chronic 
sleep fragmentation modeled in experimental con‑
ditions since intermittent hypoxia and sleep disrup‑
tion are very difficult to study separately in clinical 
settings because they occur simultaneously in apneic 
patients. Our current study has proven that long‑term 
sleep fragmentation, modeled according to severe form 
of OSA, aggravates seizures. This is in agreement with 
line that seizures are very sensitive to alterations in 
sleep pattern. Namely, good quality sleep is import‑
ant for optimal human functioning, but it is particu‑
larly essential in patients with epilepsy who may find 
themselves in a cycle of worsening seizures, further 
sleep disruption, and intractable epilepsy (Bazil, 2017). 
Moreover, this study could actually give the answer to 
the question why continuous positive airway treatment 
(CPAP) is not sufficient treatment of OSA in terms of 
seizure control (Malow et al., 2003; Bazil, 2017). Benefi‑
cial effect of CPAP on epilepsy was shown in about 40% 
of treated patients with OSA (Vaughn et al., 1996; Beran 
et al., 1999; Sonka et al., 2000), with approximately 50% 
seizure reduction in treated apneic patients (Pornsrin‑
iyom et al., 2014). Indeed, hypoxia has been already es‑
tablished as a proconvulsive factor (Jensen et al., 1991; 
1992) by facilitating glutaminergic neurotransmission 
(Rubaj et al., 2003; Yang et al., 2013), while CPAP can re‑
sult in new onset of frontal lobe seizures if applied in‑
correctly (Miano et al., 2008). Based on our results, we 
could hypothesize that sleep fragmentation also could 
represent the mechanism responsible for lowering the 
threshold to seizure in sleep apnea conditions. 
Epileptogenesis is a complex process characterized 
by an enduring predisposition to generate epileptic 
seizures and it has been found to be associated with 
changes in immunological profile (Vezzani et al., 2002; 
Lehtimäki et al., 2007; Rosa et al., 2016). In our cur‑
rent study, the levels of IL‑1β in the SF group showed 
significant increase in the thalamus, cortex and hip‑
pocampus when compared to the AC and TC groups. 
There was no statistical difference between the AC and 
TC groups, but levels of IL‑1β were higher in the activ‑
ity control group compared to sedentary controls, so 
we cannot completely rule out physical activity as the 
confounding factor for this increase. As for the levels 
of IL‑6, statistically higher levels were only found in 
the cortex of fragmented animals, and no difference 
between the groups was observed in the thalamic or 
hippocampal tissue. 
Relationship between epilepsy and IL‑1β levels are 
not completely clear in clinical studies, i.e., in some 
link has been proven and in some not (Tilgen et al., 
2002; Virta et al., 2002; Kanemoto et al., 2003; Ozkara 
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Fig. 6. Serum levels of IL‑1β and IL‑6. Levels IL‑1β and IL‑6 in animals’ serum were measured using commercial ELISA kit according to the instructions of the 
manufacturer. Difference in both, IL‑1β (A) and IL‑6 (B) levels among the three groups was not statistically significant in serum (p>0.05 vs. both TC and AC).
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et al., 2006). On the other hand, basic experimental 
studies give us better opportunity to establish a link 
between elevated levels of IL‑1β and enhanced pro‑
pensity for seizure activity. Vezzani group (1999) was 
the first to report that IL‑1β enhances focal electro‑
graphic seizures induced by kainate via glutamatergic 
signaling.
Inflammatory alterations in the rats during the 
acute epileptic events are characterized by rapid in‑
crease of IL‑1β in activated microglia and astrocytes 
(Fabene et al., 2008). Moreover, this elevated Il‑1β lev‑
el persisted even upon seizure cessation, what adds to 
the presumption on IL‑1β involvement in the mecha‑
nisms underlying the onset of spontaneous seizures 
(Allan et al., 2005; Fabene et al., 2008). The activa‑
tion of IL‑1β signaling occurs through nontranscrip‑
tion‑dependent enzymatic pathway which includes 
IL‑1R1–mediated activation of the neutral sphingo‑
myelinase (Sanchez‑Alavez et al., 2006) and the sub‑
sequent production of ceramide, which in turn acti‑
vates the tyrosine kinase protein, Src (Sanchez‑Ala‑
vez et al., 2006). IL‑1β than enhances calcium influx 
into hippocampal pyramidal cells exposed to N‑meth‑
yl‑d‑aspartate (NMDA) by phosphorylation (via Src ki‑
nase) of the NR2B subunit of the NMDA receptor com‑
plex, which is responsible for regulating its calcium 
permeability properties (Viviani et al., 2003). When 
released, IL‑1β binds with high affinity to the type 
1 IL‑1 receptor (IL‑1R1) that is expressed by hippo‑
campal neurons (Ravizza and Vezzani, 2006). In con‑
trast, when seizures evoke rapid production of IL‑1β, 
IL‑1RA is upregulated to a far lower extent and with 
a several hour delay (De Simoni et al., 2000; Ravizza 
and Vezzani, 2006). This finding suggests that the 
brain is much less effective than the periphery in in‑
ducing a crucial mechanism for rapidly terminating 
the effects of a sustained rise in endogenous IL‑1β. 
Seizures are often accompanied by extensive neuro‑
nal injury, which may account for IL‑1 production by 
microglia (Sanchez‑Alavez et al., 2006). At the cellu‑
lar level, Toll‑like receptors (TLRs), activated by sei‑
zure‑induced heath shock proteins (HSPs), induce the 
activation of nuclear factor kappa B (NF‑κB), which 
finally results in IL‑1β production (Hanke and Kielian, 
2011). TLR3 contributes to hippocampal excitability 
through its upregulation of pro‑inflammatory cyto‑
kines such as IFN‑β (Costello and Lynch, 2013). FOX3P 
is also expressed by microglia to downregulate in‑
flammatory processes through modulation of NF‑κB, 
a key inflammatory transcription factor (Chung et al., 
2010). Involvement of these mechanisms in the ele‑
vation of Il‑1β observed in our current study is still 
open question that should be addressed in one of the 
following studies. 
This mechanism has been supported by exploring 
anticonvulsive effects of IL‑1R in bicuculline induced 
seizures in rodents (Vezzani et al., 2002). In our current 
study, increased levels of IL‑1β in the cerebral cortex, 
hippocampus and thalamus found in the SF group of 
rats are congruent with theories about proconvulsive 
and neurotoxic effects of IL‑1β. Proconvulsive role 
could be achieved through several mechanisms: IL‑1β 
acts as a direct proconvulsive agent through inhibition 
of GABAA receptors and K+ efflux (Wang et al., 2000); 
inhibits glial uptake of excitatory neurotransmitters 
(Hu et al., 2000) and causes intracellular calcium ion 
surge, thus resulting in modification of voltage‑depen‑
dent ion channels and reduction of seizure threshold 
(Viviani et al., 2003; Xu et al., 2013). Other mechanisms 
could also be involved, for example IL‑1β is known to 
increase nitric oxide production in the brain (Meini et 
al., 2000), as well as to stimulate glutamatergic neu‑
rotransmission pathway and evoke neuronal hyper‑
excitability (Zhu et al., 2006). Contrary to our results, 
Sayyah et al. (2005) reported an anticonvulsive effect of 
intraventriculary injected IL‑1β in amygdala‑kindling 
mice, which could potentially be explained with IL‑1β 
ability to modulate intracellular concentration of Ca2+ 
in dose‑dependent manner, thus balancing excitato‑
ry and inhibitory neurotransmission (Zhu et al., 2006; 
Li et al., 2011). For schematic illustration of proposed 
mechanisms see Fig. 7.
Beside IL‑1β, epileptogenesis is also related to alter‑
ations in IL‑6, however its role is still unclear and giv‑
en research results are contradictory (D’Arcangelo et 
al., 2000). After seizures, IL‑6 mRNA is rapidly induced 
in the hippocampus, cortex, dentate gyrus, amygdala, 
and meninges, whereas up‑regulation of IL‑6‑receptor 
mRNA seems to be limited to the hippocampus (Le‑
htimäki et al., 2003). Several clinical studies demon‑
strated rapid and transient post‑ictal increase of IL‑6, 
which peaked at 12 h and remained for 24 h after sei‑
zures. However, some patients with chronic epilepsy 
also had higher levels of IL‑6 in basal conditions (Virta 
et al., 2002; Lehtimäki et al., 2004, 2007; Alapirtti et 
al., 2009). Different types of epilepsy showed differ‑
ent patterns in IL‑6 elevation. Taking into account the 
lower post‑ictal levels of IL‑6 in some serious forms of 
epilepsy, it can presumably act as a neuroprotective 
agent (Bauer et al., 2009). In contrast to this finding, 
there is also a report about exogenous IL‑6 attenuat‑
ed seizures in rats (Fukuda et al., 2007). Studies using 
transgenic animals reflect the double‑edged nature of 
IL‑6 with IL‑6 deficient mice more prone to seizures, 
and those with over expression of IL‑6 showing low‑
er threshold to spontaneous and NMDA‑induced sei‑
zures, probably due to reduced GABA‑mediated inhi‑
bition (De Sarro et al., 2004). 
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In our study elevated levels of IL‑1β and IL‑6 were 
found in the cortex, which is always involved in epilep‑
tic discharge (Alapirtti et al., 2018).
IL‑1β has been recognized as a fully proconvul‑
sive and proinflammatory cytokine, as it is obvious 
from our discussion above. On the other hand, IL‑6 
is a pleiotropic cytokine that has both pro‑ and an‑
ti‑inflammatory actions with predominantly anticon‑
vulsive nature (Erta et al., 2012). We found increased 
IL‑1β levels in the cortex, hippocampus and thalamus, 
with IL‑6 level was increased only in the cortex upon 
chronic sleep fragmentation. We could speculate that 
IL‑1β may contribute to epileptogenesis in our study 
by modulating or blocking IL‑6 signal transduction in 
the hippocampus and thalamus, since such a crosstalk 
between these two cytokines has been demonstrated 
in other organs (Deon et al., 2001). Namely, antagonism 
may occur at the level of signal transduction, i.e., IL‑1β 
has been shown to suppress Janus kinase‑STAT signal‑
ling by IL‑6 and antagonize IL‑6 induction of tissue in‑
hibitor of metalloproteases 1 expression (Deon et al., 
2001). Neuroinflammation depends on cytokines, glial 
and neuronal signalling, as well as on extracellular ma‑
trix, and all of the components being interconnected 
(Hrncic et al., 2018). Additionally, increased IL‑6 level 
in the cortex could be compensatory response in or‑
der to reestablish dysregulated cytokine balance. In‑
deed, upregulated IL‑6 has been revelled in conditions 
of higher neuronal excitability (Uludag et al., 2013), 
which is presumably consequence of sleep fragmenta‑
tion in our study. 
There are several limitations of this study. The 
study has been performed in male rats having in 
mind their stability regarding hormonal status. How‑
ever, further studies on female rats should be also 
done, in diestrus phase of their estrus cycle due to 
possible influence of sex hormones (Scharfman and 
MacLusky, 2014). Namely, there are important sex‑de‑
pendent differences that influence seizures and epi‑
lepsy. Studies in which pooling male and female are 
likely to obtain confusing and different results unless 
experimental conditions are fully controlled (Tan and 
Tanb, 2001). We focused herein on sleep fragmenta‑
tion effects on IL‑1β and IL‑6 production in different 
brain structures, while finding the exact cell type 
(astrocytes, microglia, neurons) as a source of these 
cytokine production should be addressed in further 
immunohistochemical studies. 
CONCLUSIONS
In summary, we have demonstrated herein that 
a 14‑day chronic sleep fragmentation increases sei‑
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Fig. 7. Schematic representation of the proposed mechanism of IL‑1β activation and subsequent production of seizure.
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zure susceptibility in rats, which is objectively prov‑
en by convulsive behavioral response and EEG anal‑
ysis and altered brain production of inflammatory 
cytokines IL‑1β and IL‑6, which could be potential 
explanation for increased seizure susceptibility. For 
sure, other mechanisms may also be involved in the 
development of brain hyperexcitability. Further stud‑
ies are needed with IL‑1β and IL‑6 antagonists, as well 
as modifications of IL‑1β and IL‑6 genes, in order to 
confirm the proexcitatory role of these cytokines in 
sleep fragmentation and find exact cellular source of 
its production.
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